Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Pediatric Genomic Medicine, |
RCV000224243 | SCV000281419 | benign | not provided | 2015-09-28 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000117452 | SCV000304191 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000321859 | SCV000460087 | likely benign | Congenital muscular dystrophy due to partial LAMA2 deficiency | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Gene |
RCV000117452 | SCV000526405 | benign | not specified | 2016-05-18 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001082331 | SCV000658783 | benign | LAMA2-related muscular dystrophy | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000576572 | SCV000677342 | benign | Merosin deficient congenital muscular dystrophy | 2017-06-23 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000117452 | SCV002050886 | likely benign | not specified | 2021-12-10 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002483197 | SCV002797898 | likely benign | Merosin deficient congenital muscular dystrophy; Muscular dystrophy, limb-girdle, autosomal recessive 23 | 2021-08-24 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000224243 | SCV005227220 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Genetic Services Laboratory, |
RCV000117452 | SCV000151669 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. | |
Clinical Genetics, |
RCV000117452 | SCV002034451 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000224243 | SCV002036217 | likely benign | not provided | no assertion criteria provided | clinical testing |